Abstract
The influence of artemisinin on the activity of human platelet soluble guanylyl cyclase was investigated. Artemisinin (0.1-100 microM) had no effect on the basal activity of the enzyme. Artemisinin inhibited in a concentration-dependent manner the sodium nitroprusside-induced activation of human platelet guanylyl cyclase with an IC(50) value 5.6 microM. Artemisinin (10 microM) also inhibited (by 71+/-4.0%) the activation of the enzyme by the thiol-dependent nitric oxide (NO) donor, the derivative of furoxan, 3,4-dicyano-1,2,5-oxadiazole 2-oxide (10 microM), but did not influence the stimulation of soluble guanylyl cyclase by protoporphyrin 1X. Inhibition of guanylyl cyclase activation by NO donors but not by protoporphyrin 1X represents a possible additional mechanism of the pharmacological action of this drug.
References
May 7, 1976·Analytical Biochemistry·M M Bradford
Aug 1, 1990·Molecular and Biochemical Parasitology·F KawamotoR E Sinden
May 1, 1990·Chest·P CharoenpanS Tanomsup
May 31, 1985·Science·D L Klayman
Feb 1, 1981·Canadian Journal of Physiology and Pharmacology·C A GruetterL J Ignarro
Jul 1, 1994·The Journal of Experimental Medicine·M C SeguinS J Green
Sep 1, 1995·The Journal of Experimental Medicine·D GhigoA Bosia
Feb 1, 1995·British Journal of Pharmacology·R FerioliA Gasco
Apr 29, 1994·Journal of Medicinal Chemistry·G H PosnerW Asawamahasadka
Mar 8, 1996·Biochemical Pharmacology·H AtamnaH Ginsburg
Dec 1, 1996·The Journal of Pediatrics·W DriscollF C Morin
Oct 1, 1996·Postgraduate Medical Journal·G BrownT Phang
Feb 28, 1997·Journal of Medicinal Chemistry·S PaitayatatY Yuthavong
Jun 2, 1997·FEBS Letters·M V IgnatushchenkoM K Riscoe
Oct 1, 1996·Parasite Immunology·I W JonesR E Sinden
Jun 1, 1997·Intensive Care Medicine·F BruneelF Vachon
Feb 12, 1998·Trends in Pharmacological Sciences·A J Hobbs
Feb 24, 1999·Parasitology·N FavreW Rudin
Oct 3, 1999·Angewandte Chemie·Y WuY L Wu
Mar 22, 2000·British Journal of Pharmacology·A Y KotsI S Severina